Cue Biopharma (CUE) stock news · rev $27.5M
Cue Biopharma (CUE) is a biotechnology company listed on US.
This CUE news page leads with what Cue Biopharma filed — not a scraped headline mill.
No cached 8-K sentence for CUE yet. We will not pad this page with generic market recap.
Latest reported CUE revenue for 2025-12-31 was $27.5M. Net income was -$26.6M. Revenue was up 195.7% from 2024-12-31 to 2025-12-31. CUE currently screens at market cap $59.5M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CUE stock page; for the tape open the quote page.
CUE stock news FAQ
What are CUE's latest revenue and net income?
Latest cached Cue Biopharma (CUE) revenue for Dec 31, 2025 was $27.5M. Net income was -$26.6M. Statements: https://lician.com/financials/cue
How did CUE revenue change from the prior cached period?
Cached Cue Biopharma (CUE) revenue was up 195.7% from $9.3M (Dec 31, 2024) to $27.5M (Dec 31, 2025). Statements: https://lician.com/financials/cue
What is CUE's market cap?
Cue Biopharma (CUE) market cap is $59.5M on the latest cached fundamentals snapshot.
What kind of company is CUE?
Cue Biopharma (CUE) is a biotechnology company listed on US.
Where is CUE stock news listed?
Cached stock news for Cue Biopharma (CUE) is listed at https://lician.com/news/cue. Filings: https://lician.com/sec/cue
Not investment advice.